Overall Net-Zero Target: Bristol Myers Squibb commits to reach net-zero greenhouse gas emissions across the value chain by 2050. Near-Term Targets: Bristol Myers Squibb (BMS) commits to reduce absolute scope 1 and 2 GHG emissions 54.6% by 2033 from a 2022 base year.* BMS also commits to reduce absolute scope 3 GHG emissions from fuel and energy related activities 54.6% within the same timeframe.* BMS further commits that 75% of its suppliers by emissions covering purchased goods and services, capital goods, and upstream transportation and distribution will have science-based targets by 2028. *The target boundary includes biogenic land-related emissions and removals from bioenergy feedstocks. Long-Term Targets: BMS commits to reduce absolute scope 1 and 2 GHG emissions 90% by 2050 from a 2022 base year.* BMS also commits to reduce absolute scope 3 GHG emissions 90% within the same timeframe.* *The target boundary includes biogenic land-related emissions and removals from bioenergy feedstocks.